TOL plasmid pWW0 in constructed halobenzoate-degrading Pseudomonas strains: prevention of meta pathway.
The hybrid pathway for chlorobenzoate metabolism was studied in WR211 and WR216, which were derived from Pseudomonas sp. B13 by acquisition of TOL plasmid pWW0 from Pseudomonas putida mt-2. Chlorobenzoates are utilized readily by these strains when meta cleavage of chlorocatechols is suppressed. When WR211 utilizes 3-chlorobenzoate (3CB), the expression of catechol 2,3-dioxygenase (C23O) and the catabolic activities for chloroaromatics via the ortho pathway coexist as a consequence of inactivation of the meta cleavage activity by 3-chlorocatechol. Utilization of 4-chlorobenzoate (4CB) by WR216 presupposes the suppression of C23O by a spontaneous mutation in the structural gene, so that 4-chlorocatechol is not misrouted into the meta pathway. Such C23O- mutants were also selected when WR211 was grown continuously on 3CB. Our data explain why the phenotypic characters 3CB+ and Mtol+ (m-toluate) are compatible, whereas 4CB+ and Mtol+ are incompatible.
D001565:Benzoates / Q000378:metabolism*; D050548:Catechol 1,2-Dioxygenase; D050557:Catechol 2,3-Dioxygenase; D002396:Catechols / Q000378:metabolism; D002723:Chlorobenzoates / Q000378:metabolism*; D049308:Dioxygenases; D004790:Enzyme Induction; D010105:Oxygenases / Q000378:metabolism; D010957:Plasmids; D011549:Pseudomonas / Q000235:genetics*
D001565:Benzoates; D002396:Catechols; D002723:Chlorobenzoates; C031136:3-methylcatechol; C031137:3-chlorocatechol; C009503:3-toluic acid; D010105:Oxygenases; D049308:Dioxygenases; D050548:Catechol 1,2-Dioxygenase; D050557:Catechol 2,3-Dioxygenase